Related references
Note: Only part of the references are listed.Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2
Yejin Jang et al.
SCIENTIFIC REPORTS (2021)
Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
Tianling Ou et al.
PLOS PATHOGENS (2021)
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures
Desiree Schuetz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
Martina Morokutti-Kurz et al.
PLOS ONE (2021)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
The Use of Antimalarial Drugs against Viral Infection
Sarah D'Alessandro et al.
MICROORGANISMS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
An Infectious cDNA Clone of SARS-CoV-2
Xuping Xie et al.
CELL HOST & MICROBE (2020)
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Michele Costanzo et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Eli S. Rosenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
Yu Bo et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Matthieu Million et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Matthieu Mahevas et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
Jennifer A. Aguiar et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
A systematic review on the ef ficacy and safety of chloroquine for the treatment of COVID-19
Andrea Cortegiani et al.
JOURNAL OF CRITICAL CARE (2020)
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
Markus Hoffmann et al.
NATURE (2020)
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
Pauline Maisonnasse et al.
NATURE (2020)
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study
Andrew Ip et al.
PLOS ONE (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
Zi-Ning Lei et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity
Suzanne J. F. Kaptein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
Mathieu Gendrot et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
Joseph Magagnoli et al.
MED (2020)
The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series
Hao Zeng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
Mario Mauthe et al.
AUTOPHAGY (2018)
Drug repurposing of quinine as antiviral against dengue virus infection
Shilu Malakar et al.
VIRUS RESEARCH (2018)
Hydroxychloroquine retinopathy - implications of research advances for rheumatology care
April Jorge et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
The Fever Tree: from Malaria to Neurological Diseases
Sara Eyal
TOXINS (2018)
Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?
AMAR SRINIVASA et al.
JOURNAL OF RHEUMATOLOGY (2017)
Inhibition of Influenza Virus Replication by Targeting Broad Host Cell Pathways
Isabelle Marois et al.
PLOS ONE (2014)
Chloroquine cardiomyopathy - a review of the literature
Ernst Toennesmann et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2013)
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Jane Achan et al.
MALARIA JOURNAL (2011)
Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers
Julius O. Soyinka et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells
Stephanie Bertram et al.
JOURNAL OF VIROLOGY (2010)
Share Paper
